Clinical trial
Establishing Novel Functional Biomarkers for Fragile X Syndrome
NCT06293027 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Establishing Novel Functional Biomarkers for Fragile X Syndrome
- Lead sponsor
- IRCCS Fondazione Stella Maris
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- December 15, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.